A subgroup analysis of BRCA2 mutation showed an increase in the frequency of BRCA2 mutation among CRC patients (OR = 1.62, 95% CI = 1.15–2.28, P = 0.006), with no statistical heterogeneity (I2 = 9%) (Fig. 2). Here, BRCA2 is linked to colorectal carcinoma.